Fructose-coated nanoparticles: a promising drug nanocarrier for triple-negative breast cancer therapy
- 16 October 2014
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 50 (100) , 15928-15931
Abstract
Overexpression of GLUT5 in breast cancer cell lines leads to extensive uptake of fructose bearing nanoparticles.Keywords
Funding Information
- Australian Research Council (DP130101625)
This publication has 29 references indexed in Scilit:
- Precision glycopolymers and their interactions with lectinsEuropean Polymer Journal, 2013
- Effect of shell-crosslinking of micelles on endocytosis and exocytosis: acceleration of exocytosis by crosslinkingBiomaterials Science, 2012
- Effect of Cross-Linking on the Performance of Micelles As Drug Delivery Carriers: A Cell Uptake StudyBiomacromolecules, 2012
- Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administrationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Mediating Tumor Targeting Efficiency of Nanoparticles Through DesignNano Letters, 2009
- Nanoparticle therapeutics: an emerging treatment modality for cancerNature Reviews Drug Discovery, 2008
- Elucidating the Mechanism of Cellular Uptake and Removal of Protein-Coated Gold Nanoparticles of Different Sizes and ShapesNano Letters, 2007
- Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian CellsNano Letters, 2006
- Molecular Classification and Molecular Forecasting of Breast Cancer: Ready for Clinical Application?Journal of Clinical Oncology, 2005
- pH‐Dependent Self‐Assembly: Micellization and Micelle–Hollow‐Sphere Transition of Cellulose‐Based CopolymersAngewandte Chemie International Edition, 2003